Water Cooler Chat: Best Practice on Setting Health-Based Cleaning Limits in a Multi-product Facility
David O’Connell
PCI, Director of Scientific Affairs
Gareth Phillips
PCI, Senior Development Scientist
Dean Calhoun
Affygility Solutions
International potent compound safety expert, Founder and CEO
When different medicinal products are produced in shared facilities, the potential for cross-contamination is a concern. Medicinal products provide a benefit to the intended patient; however, as a cross contaminant, they provide no benefit and may even pose a risk. Hence, the presence of such contaminants should be managed according to the risk posed which in turn are related to levels that can be considered safe for all populations. Learn more about setting Allowable Daily Exposure (ADE)/Permitted Daily Exposure (PDE) limits.
Total Page Views: 2050
